Koufopoulos Nektarios, Kokkali Stefania, Antoniadou Foteini, Dimas Dionysios T, Missitzis Ioannis L
Pathology, Attikon University Hospital, Medical School of Athens, Athens, GRC.
Oncology, Saint Savvas Cancer Hospital, Athens, GRC.
Cureus. 2019 Jul 22;11(7):e5188. doi: 10.7759/cureus.5188.
Matrix-producing carcinoma (MPC) is a rare subtype of metaplastic breast carcinoma (MBC) that was first described in 1989 by Wargotz and Norris. It accounts for less than 1% of breast carcinomas and has distinctive clinical, morphological, and immunohistochemical features. Histologically it consists of invasive carcinoma of no special type with transition to cartilaginous or osseous matrix without a spindle cell component. Data on this entity are limited with the literature consisting mostly of case reports and a small number of case series. We report a case of matrix-producing breast carcinoma, with excellent clinical outcome. We also discuss the histogenesis, imaging, histological, and immunohistochemical characteristics, treatment, and focus on the differential diagnosis of this rare tumor.
产基质癌(MPC)是化生性乳腺癌(MBC)的一种罕见亚型,于1989年由瓦尔戈茨和诺里斯首次描述。它占乳腺癌的比例不到1%,具有独特的临床、形态学和免疫组化特征。组织学上,它由非特殊类型的浸润性癌组成,可向软骨或骨基质转变,无梭形细胞成分。关于这一实体的数据有限,文献大多由病例报告和少数病例系列组成。我们报告一例产基质乳腺癌,临床结局良好。我们还讨论了其组织发生、影像学、组织学和免疫组化特征、治疗,并着重于这种罕见肿瘤的鉴别诊断。